Prescribing incentive schemes: a useful approach?
AR Mason, MF Drummond, JA Hunter… - … Health Economics and …, 2005 - Springer
Introduction From 2000 to 2004, primary care organisations (PCOs) in England were legally
required to operate a prescribing incentive scheme for their general practices. A statutory …
required to operate a prescribing incentive scheme for their general practices. A statutory …
A health insurance company–initiated multifaceted intervention for optimizing acid-suppressing drug prescriptions in primary care: a randomized controlled trial
HM Smeets, NJ De Wit, NPA Zuithoff… - Archives of internal …, 2010 - jamanetwork.com
Objective To evaluate the effectiveness of a health insurance company–initiated intervention
strategy aimed at optimizing acid-suppressing drug (ASD) prescriptions in primary care …
strategy aimed at optimizing acid-suppressing drug (ASD) prescriptions in primary care …
Improving GPs' knowledge of the benefits and harms of treatment to support decision making in multimorbidity: qualitative research and co-design of a novel electronic …
JS Treadwell - 2023 - ora.ox.ac.uk
Background General practitioners (GPs) regularly prescribe prolonged treatments for long-
term conditions. However, GPs may benefit from further understanding of the absolute …
term conditions. However, GPs may benefit from further understanding of the absolute …
A health insurance company-initiated practice support intervention for optimizing acid-suppressing drug prescriptions in primary care
HM Smeets, AW Hoes, NPA Zuithoff… - European journal of …, 2011 - journals.lww.com
Background A health insurance-initiated programme to improve cost-effectiveness of acid-
suppressing drugs (ASDs). Aim To evaluate the effect of two different interventions of …
suppressing drugs (ASDs). Aim To evaluate the effect of two different interventions of …
Examining Policy, Enabler and Access Factor Effects on US State Medicaid Pharmaceutical Utilization and Expenditures
EK Eghan - 2021 - search.proquest.com
Prescription drug expenditures and utilization are the fastest growing and most widely
varying expenditures within Medicaid programs across US states. The passage of the …
varying expenditures within Medicaid programs across US states. The passage of the …
[图书][B] Prescription et utilisation optimales des médicaments au Canada: défis et possibilités
IS Sketris, H Lummis, EL Ingram - 2007 - epe.lac-bac.gc.ca
PRESCRIPTION ET UTILISATION OPTIMALES DES MÉDICAMENTS AU CANADA : DÉFIS
ET POSSIBILITÉS Page 1 PRESCRIPTION ET UTILISATION OPTIMALES DES …
ET POSSIBILITÉS Page 1 PRESCRIPTION ET UTILISATION OPTIMALES DES …
외국의처방인센티브제도와시사점
김동숙 - HIRA 정책동향, 2012 - oldkmbase.medric.or.kr
2000 년동안 EU 회원국의 1 인당 평균 약품비는 79.9% 증가했고, 스페인도 일차의료지출의
50% 이상을 차지하기도 하는 등 유럽에서는 증가하는 약제비 지출을 감소하는 것이 …
50% 이상을 차지하기도 하는 등 유럽에서는 증가하는 약제비 지출을 감소하는 것이 …
[PDF][PDF] 외국의처방점검제도와처방지표고찰
김동숙 - 2010 - repository.hira.or.kr
약제급여 적정성 평가에 도입 가능한 평가항목과 지표를 살펴보기 위해 외국의 공적보험에서의
의약품 사용평가 관련 제도와 처방평가 지표를 검토하였다. 현재 국내뿐만 아니라 외국에서도 …
의약품 사용평가 관련 제도와 처방평가 지표를 검토하였다. 현재 국내뿐만 아니라 외국에서도 …